Bain Capital
Scroll Up to Approach

Portfolio

Bain Capital Life Sciences pursues investments in pharmaceutical, biotechnology, medical device, diagnostic, and life science tool companies across the globe.

Portfolio listing as of August 1, 2025.

Layout:

Abcuro

2023 / Active

ADARx Pharmaceuticals

2023 / Active

Affera

2021 / Former

Affinivax

2020 / Former

Aiolos Bio

2023 / Former

Alkeus Pharmaceuticals

2022 / Active

Amunix Pharmaceuticals

2021 / Former

Amylyx Pharmaceuticals

2021 / Former

Angitia

2024 / Active

Annexon Biosciences

2018 / Active

Apreo

2025 / Active

Aptinyx

2017 / Former

Arcutis Biotherapeutics

2018 / Former

Areteia Therapeutics

2022 / Active

Atea Pharmaceuticals

2020 / Active

Atsena

2025 / Active

Avistone Pharmaceuticals

2021 / Active

C4 Therapeutics

2020 / Active

Cabaletta Bio

2023 / Active

Cardurion Pharmaceuticals

2021 / Active

Cerevasc

2024 / Active

Cerevel Therapeutics

2018 / Former

Cidara

2024 / Active

Constellation Pharmaceuticals

2019 / Former

Dianthus

2024 / Active

Dicerna Pharmaceuticals

2017 / Former

Disc Medicine

2023 / Active

Dynavax Technologies

2019 / Former

Emalex Biosciences

2022 / Active

EyeBio

2023 / Former

FIS

2023 / Active

Freenome

2020 / Active

Gynesonics

2018 / Former

HeartFlow

2023 / Active

Hugel Pharma

2017 / Former

Imperative Care

2019 / Active

InflaRX

2017 / Former

Invivyd

2021 / Active

JenaValve Technology

2020 / Active

Jnana Therapeutics

2022 / Former

Kailera

2024 / Active

Kestra Medical Technologies

2017 / Active

Kymera Therapeutics

2020 / Former

Kyverna Therapeutics

2023 / Active

Marinus Pharmaceuticals

2017 / Former

Merida Biosciences

2024 / Active

Mersana Therapeutics

2020 / Active

Mitsubishi Tanabe Pharma

2025 / Active

Natera

2022 / Former

NewAmsterdam Pharma

2020 / Active

Nimbus Therapeutics

2022 / Active

Nurix Therapeutics

2022 / Former

Nuvalent

2021 / Former

Olema Oncology

2024 / Active

Pharvaris

2019 / Active

Rapid Micro Biosciences

2018 / Active

Replimune Group

2017 / Former

Revolution Medicines

2020 / Former

River Renal

2020 / Active

Rivus Pharmaceuticals

2022 / Active

Savara

2019 / Active

Serán

2024 / Active

Solid Biosciences

2017 / Active

SpringWorks Therapeutics

2017 / Former

Synthekine

2021 / Active

Syros Pharmaceuticals

2020 / Active

Tenacia Biotechnology

2022 / Active

Third Harmonic Bio

2022 / Former

Thrive Earlier Detection

2020 / Former

Timberlyne

2025 / Active

Upstream Bio

2023 / Active

ViaCyte

2018 / Former

X4 Pharmaceuticals

2019 / Active

Xilio Therapeutics

2021 / Active
Scroll down to People
_